| NCT02593175 | M.D. Anderson Cancer Center | Stage I Breast Cancer AJCC v7|Stage IA Breast Cancer AJCC v7|Stage IB Breast Cancer AJCC v7|Stage II Breast Cancer AJCC v6 and v7|Stage IIA Breast Cancer AJCC v6 and v7|Stage IIB Breast Cancer AJCC v6 and v7|Stage III Breast Cancer AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIC Breast Cancer AJCC v7|Triple-Negative Breast Carcinoma | 2016-11-03 | PHASE2 |
| NCT00101907 | Amgen | Lung Cancer|Pancreatic Cancer|Esophageal Cancer | 2004-12 | PHASE1 |
| NCT00940316 | Northwestern University|Genentech, Inc.|OSI Pharmaceuticals|Amgen | Colorectal Cancer | 2010-01-18 | PHASE2 |
| NCT05993455 | Korea University Anam Hospital | Efficacy | 2023-07-03 | PHASE2 |
| NCT02643056 | Southern Europe New Drug Organization|Clinical Trial Unit Ente Ospedaliero Cantonale | Advanced Head and Neck Squamous Cancer | 2011-01 | PHASE2 |
| NCT02904031 | Gruppo Oncologico del Nord-Ovest | Elderly Metastatic Colorectal Cancer Patients | 2016-07 | PHASE2 |
| NCT01418742 | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH|ClinAssess GmbH | Colorectal Carcinoma | 2011-08 | PHASE2 |
| NCT04185883 | Amgen | Advanced Solid Tumors|Kirsten Rat Sarcoma (KRAS) pG12C Mutation | 2019-12-17 | PHASE1 |
| NCT01234324 | AIO-Studien-gGmbH|Amgen|WiSP Wissenschaftlicher Service Pharma GmbH | Stomach Neoplasms|Gastroesophageal Junction Neoplasms | 2010-10 | PHASE2 |
| NCT06509126 | National Cancer Institute, Naples | Colorectal Cancer Stage IV | 2024-06-12 | PHASE3 |
| NCT05863195 | ECOG-ACRIN Cancer Research Group|National Cancer Institute (NCI) | Metastatic Colorectal Carcinoma|Metastatic Malignant Neoplasm in the Liver|Stage IV Colorectal Cancer AJCC v8|Unresectable Colorectal Carcinoma | 2023-10-19 | PHASE3 |
| NCT01508000 | European Organisation for Research and Treatment of Cancer - EORTC|Amgen|Roche Pharma AG | Colorectal Cancer Metastatic|Liver Metastases|KRAS Wild Type Colorectal Cancer | 2013-06 | PHASE2 |
| NCT01504477 | Georgetown University|Millennium Pharmaceuticals, Inc. | Colorectal Cancer | 2011-12 | PHASE1|PHASE2 |
| NCT00364013 | Amgen | Metastatic Colorectal Cancer | 2006-08-01 | PHASE3 |
| NCT04034173 | Ludwig-Maximilians - University of Munich|Amgen|ClinAssess GmbH | Treatment Related Cancer | 2019-08-01 | PHASE2 |
| NCT00792363 | Vejle Hospital | Metastatic Colorectal Cancer | 2008-11 | PHASE2 |
| NCT01312493 | UNC Lineberger Comprehensive Cancer Center|Amgen | Head and Neck Cancer | 2011-12 | PHASE2 |
| NCT00332163 | Amgen | Metastatic Colorectal Cancer|Skin Rash|Skin Toxicities|Colon Cancer|Colorectal Cancer | 2006-04 | PHASE2 |
| NCT02399943 | University Health Network, Toronto | Colorectal Cancer|KRAS Wildtype|NRAS Wildtype|BRAF Wildtype | 2015-06 | PHASE2 |
| NCT01139138 | The Queen Elizabeth Hospital|Amgen|Novartis | Colorectal Cancer|Colorectal Carcinoma|Colorectal Tumors|Neoplasms, Colorectal | 2010-06 | PHASE1|PHASE2 |
| NCT00779454 | Vejle Hospital | Cholangiocarcinoma | 2008-09 | PHASE2 |
| NCT03983993 | Emory University|GlaxoSmithKline|National Institutes of Health (NIH)|National Cancer Institute (NCI) | Advanced Microsatellite Stable Colorectal Carcinoma|Metastatic Microsatellite Stable Colorectal Carcinoma|Microsatellite Stable|RAS Wild Type|Stage IV Colorectal Cancer AJCC v8|MSI-H Colorectal Cancer | 2019-10-15 | PHASE2 |
| NCT07094204 | Astellas Pharma Inc | Solid Tumor|Non-Small-Cell Lung Cancer|Pancreatic Ductal Adenocarcinoma|Colorectal Cancer | 2025-07-25 | PHASE1 |
| NCT01328171 | AIO-Studien-gGmbH|Amgen|ClinAssess GmbH | Metastatic Colorectal Cancer | 2011-04 | PHASE2 |
| NCT05030493 | Takeda | Colorectal Cancer | 2021-08-31 | |
| NCT02301962 | Dr. Reddy´s Laboratories Limited|Amgen | Cancer | 2015-07-28 | PHASE4 |
| NCT07318389 | M.D. Anderson Cancer Center | Dynamic Tumor Resistance|Metastatic Colorectal Cancer | 2026-06-10 | EARLY_PHASE1 |
| NCT00339183 | Amgen | Metastatic Colorectal Cancer | 2006-06-30 | PHASE3 |
| NCT05786924 | Institut de Recherches Internationales Servier | Non-small Cell Lung Cancer|Histiocytic Neoplasm|Histiocytosis|BRAF Gene Mutation|BRAF V600E|BRAF V600 Mutation|BRAF Mutation-Related Tumors|BRAF|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Lung Cancer|Recurrent Lung Cancer|Recurrent Lung Non-Small Cell Carcinoma|NSCLC|Solid Tumor|Solid Carcinoma|KRAS G12D|KRAS G12V|KRAS Mutation-Related Tumors|NRAS Gene Mutation|Thyroid Cancer|Thyroid Carcinoma|Colorectal Cancer|Colorectal Carcinoma|Recurrent Histiocytic and Dendritic Cell Neoplasm|Brain Metastases|Recurrent NSCLC|KRAS G13C|Acquired Resistance to KRAS G12C Inhibitor|KRAS G12A|KRAS G12F|KRAS G12R|KRAS G13D | 2023-04-18 | PHASE1|PHASE2 |
| NCT00788957 | NantBioScience, Inc. | Colon Cancer|Colorectal Cancer|Gastrointestinal Cancer|Metastatic Colorectal Cancer|Rectal Cancer | 2008-10-27 | PHASE1|PHASE2 |
| NCT01260415 | University Health Network, Toronto | Colorectal Cancer|Liver Metastases | 2010-08 | PHASE2 |
| NCT05177796 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Breast Inflammatory Carcinoma|Invasive Breast Carcinoma|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Triple-Negative Breast Carcinoma | 2022-03-11 | PHASE2 |
| NCT00089635 | Amgen | Colorectal Cancer|Metastases | 2004-08-01 | PHASE2 |
| NCT00094835 | Amgen | Lung Cancer|Non-Small Cell Lung Cancer | 2005-01 | PHASE1|PHASE2 |
| NCT01776307 | Sumitomo Pharma America, Inc. | Colorectal Cancer | 2012-03 | PHASE2 |
| NCT02394834 | Takeda | Colorectal Cancer | 2015-05-29 | |
| NCT05945875 | Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI) | Head and Neck Squamous Cell Carcinoma|Recurrent Head and Neck Squamous Cell Carcinoma | 2023-10-03 | PHASE1 |
| NCT01126112 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Amgen | Colorectal Cancer | 2010-05 | PHASE2 |
| NCT00115765 | Amgen | Colorectal Cancer | 2005-06-01 | PHASE3 |
| NCT01128387 | University of Wisconsin, Madison|Amgen | Cancer | 2010-05 | PHASE1|PHASE2 |
| NCT00894504 | SCRI Development Innovations, LLC|Amgen|Eli Lilly and Company | Metastatic Breast Cancer | 2010-02 | PHASE2 |
| NCT01172717 | Boston Medical Center|Amgen | Carcinoid Syndrome | 2013-07 | PHASE2 |
| NCT00601627 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Pancreatic Cancer | 2009-06 | PHASE2 |
| NCT01991873 | AIO-Studien-gGmbH|ClinAssess GmbH|Amgen | Metastatic Colorectal Cancer | 2014-04 | PHASE2 |
| NCT00004879 | Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) | Colorectal Cancer|Esophageal Cancer|Kidney Cancer|Lung Cancer|Pancreatic Cancer|Prostate Cancer | 2000-04 | PHASE1 |
| NCT01130701 | University of Massachusetts, Worcester | Pancreatic Cancer | 2010-05 | PHASE2 |
| NCT01634880 | Athanassios Argiris|University of Pittsburgh|University of North Carolina, Chapel Hill | Salivary Gland Malignancy | 2012-07 | PHASE2 |
| NCT03142516 | Grupo Espanol Multidisciplinario del Cancer Digestivo|Amgen|Pivotal S.L. | Colorectal Neoplasms|Colorectal Carcinoma|Colorectal Cancer Metastatic|Neoplasm Metastasis | 2017-10-31 | PHASE2 |
| NCT00814619 | Swiss Cancer Institute | Colorectal Cancer | 2008-11 | PHASE2 |
| NCT00111761 | Amgen | Colorectal Cancer | 2002-07 | PHASE2 |
| NCT01320254 | Hannover Medical School | Cholangiocarcinomas | 2011-06 | PHASE2 |
| NCT06978400 | Blokhin´s Russian Cancer Research Center|City Clinical Oncology Hospital No 1|Moscow City Oncology Hospital No. 62|The Loginov MCSC MHD|Moscow Multidisciplinary Clinical Center "Kommunarka" | Neoplasms | 2025-03-01 | PHASE2 |
| NCT04840472 | Stanford University|American Cancer Society, Inc. | Head and Neck Cancer | 2021-03-30 | PHASE1 |
| NCT04787341 | Gruppo Oncologico del Nord-Ovest|Bayer|Amgen | Colorectal Cancer | 2020-12-15 | PHASE2 |
| NCT03635021 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Amgen | Colorectal Cancer | 2018-10-15 | PHASE3 |
| NCT00346099 | NSABP Foundation Inc|Amgen | Rectal Cancer|Neoplasm Metastasis | 2006-06 | PHASE2 |
| NCT03751176 | Grupo Espanol Multidisciplinario del Cancer Digestivo|Amgen|Pivotal S.L. | Colorectal Cancer Metastatic | 2018-11-08 | PHASE2 |
| NCT02818725 | UNICANCER | Infiltrating Urothelial Carcinoma|KRAS Gene Mutation | 2010-06 | PHASE3 |
| NCT01379807 | Grupo Gallego de Investigaciones Oncologicas|Amgen|Trial Form Support S.L. | Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma | 2010-12 | PHASE2 |
| NCT00658658 | Amgen | Solid Tumors | 2008-03 | PHASE1 |
| NCT00425204 | Amgen | Colorectal Cancer|Non-Small Cell Lung Cancer|Prostate Cancer|Solid Tumors|Advanced Renal Cell Carcinoma | 2004-03 | PHASE2 |
| NCT05007132 | Dominik Paul Modest | Metastatic Colorectal Cancer | 2021-12-17 | PHASE2 |
| NCT00824785 | Royal Marsden NHS Foundation Trust | Oesophago-gastric Cancer | 2008-05 | PHASE3 |
| NCT01285778 | Grupo Espanol Multidisciplinario del Cancer Digestivo|Amgen|Trial Form Support S.L. | Anal Squamous Cell Carcinoma | 2010-10 | PHASE2 |
| NCT01591421 | Canadian Cancer Trials Group|Pfizer | Metastatic Colorectal Cancer | 2012-09-06 | PHASE1|PHASE2 |
| NCT02008383 | John Strickler, M.D.|Exelixis | Colorectal Cancer | 2014-01 | PHASE1 |
| NCT02613221 | Takeda | Colorectal Cancer | 2015-12-07 | PHASE1|PHASE2 |
| NCT04163952 | Rutgers, The State University of New Jersey|National Cancer Institute (NCI) | Locally Advanced Skin Squamous Cell Carcinoma|Metastatic Skin Squamous Cell Carcinoma|Recurrent Skin Squamous Cell Carcinoma | 2020-01-31 | PHASE1 |
| NCT02089737 | Takeda | Advanced or Recurrent Colorectal Cancer | 2010-06 | |
| NCT05638295 | National Cancer Institute (NCI) | Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm | 2024-08-01 | PHASE2 |
| NCT00550836 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI) | Pancreatic Cancer | 2009-03 | PHASE2 |
| NCT06998940 | SWOG Cancer Research Network|National Cancer Institute (NCI) | Locally Advanced Pancreatic Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma | 2026-04-01 | PHASE3 |
| NCT00586443 | Herbert Hurwitz, MD|Novartis|Genentech, Inc.|Amgen | Solid Tumors | 2007-11 | PHASE1 |
| NCT01389414 | Prof. Massimo Aglietta | Biliary Carcinoma | 2010-05 | PHASE2 |
| NCT01038037 | Vejle Hospital | Non Small Cell Lung Cancer | 2010-01 | PHASE2 |
| NCT01443065 | UNICANCER | Malignant Neoplasm of Esophagus|Malignant Neoplasm of Stomach | 2011-01 | PHASE2 |
| NCT01443377 | National Center for Tumor Diseases, Heidelberg | Rectal Cancer | 2011-07 | PHASE2 |
| NCT01627379 | AIO-Studien-gGmbH|Amgen|Assign Data Management and Biostatistics GmbH|Assign Clinical Research GmbH | Esophageal Squamous Cell Cancer | 2012-05 | PHASE3 |
| NCT00853931 | British Columbia Cancer Agency | Metastatic Colorectal Cancer | 2009-10 | NA |
| NCT00547157 | Amgen | Cancer|Head and Neck Cancer|Oncology|Squamous Cell Carcinoma | 2007-11 | PHASE2 |
| NCT00563316 | Amgen | Metastatic Colorectal Cancer | 2008-03 | PHASE1 |
| NCT01351038 | Arbeitsgemeinschaft medikamentoese Tumortherapie|Amgen | KRAS Wild Type|Resectable Type II Gastric Adenocarcinoma | | PHASE2 |
| NCT01017653 | Annick Desjardins|Amgen | Malignant Glioma of Brain | 2010-02 | PHASE2 |
| NCT05121038 | Anup Kasi|Cend Therapeutics Inc. | Colon Cancer|Pancreas Cancer|Digestive Cancer | 2021-10-20 | PHASE1|PHASE2 |
| NCT00667420 | Massachusetts General Hospital | Esophageal Adenocarcinoma|Gastric Adenocarcinoma | 2008-04 | PHASE1|PHASE2 |
| NCT03043950 | iOMEDICO AG|Amgen | Metastatic Colorectal Cancer|RAS Wild-type | 2017-01-25 | |
| NCT01129154 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain|Cliniques Universitaires UCL de Mont-Godinne, Dr Joseph Kerger|Cliniques Saint-Pierre Ottignies, Dr Lionel Duck | Carcinoma, Squamous Cell | 2010-08 | PHASE2 |
| NCT06332079 | Gruppo Oncologico del Nord-Ovest | Colorectal Cancer Metastatic | 2024-03-13 | PHASE2 |
| NCT03940131 | King Abdullah Medical City | Metastatic Colorectal Cancer | 2020-06-10 | PHASE2 |
| NCT05198934 | Amgen | Colorectal Cancer (CRC) | 2022-04-19 | PHASE3 |
| NCT06819228 | Vanderbilt-Ingram Cancer Center | HNSCC|HNSCC,Larynx, Pharynx and Oral Cavity|SCC - Squamous Cell Carcinoma | 2025-04-17 | EARLY_PHASE1 |
| NCT01296035 | Women and Infants Hospital of Rhode Island|Amgen | Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer | 2011-02 | PHASE2 |
| NCT00508404 | Amgen | Metastatic Colorectal Cancer | 2007-05-09 | PHASE2 |
| NCT00979212 | Radiation Therapy Oncology Group|National Cancer Institute (NCI) | Lung Cancer | 2011-02 | PHASE2 |
| NCT06194877 | MapKure, LLC | Colorectal Cancer|Pancreatic Ductal Cancer|Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers | 2024-04-18 | PHASE1 |
| NCT00756444 | Amgen|Takeda | Squamous Cell Carcinoma of Head and Neck | 2008-10-21 | PHASE2 |
| NCT00757172 | Alliance for Clinical Trials in Oncology|National Cancer Institute (NCI)|Amgen | Adenocarcinoma of the Gastroesophageal Junction|Esophageal Cancer | 2009-01 | PHASE2 |
| NCT00091806 | Amgen | Tumors|Oncology|Solid Tumors | 2004-08 | PHASE1 |
| NCT02980510 | UNICANCER | Metastatic Colorectal Cancer | 2016-12 | PHASE2 |
| NCT03186326 | Federation Francophone de Cancerologie Digestive | Metastatic Colorectal Cancer|MSI | 2018-04-24 | PHASE2 |
| NCT01312857 | Memorial Sloan Kettering Cancer Center|Amgen | Metastatic Colorectal Cancer | 2011-03-07 | PHASE2 |
| NCT00610948 | UNC Lineberger Comprehensive Cancer Center|National Cancer Institute (NCI) | Unspecified Adult Solid Tumor, Protocol Specific | 2008-03 | PHASE1 |
| NCT01158248 | Medical University Innsbruck | Cervical Cancer | 2010-02 | PHASE2 |
| NCT02448810 | Baxalta now part of Shire | Metastatic Colorectal Cancer | 2015-06-15 | PHASE2 |
| NCT05468892 | University of Campania Luigi Vanvitelli | Metastatic Colon Cancer | 2019-10-29 | PHASE2 |
| NCT00418938 | Amgen | Cancer|Colon Cancer|Colorectal Cancer|Metastatic Cancer|Rectal Cancer|Metastatic Colorectal Cancer | 2006-11-01 | PHASE2 |
| NCT00836277 | Weijing Sun, MD, FACP|Amgen | Esophageal Cancer | 2009-05 | PHASE2 |
| NCT01226719 | SCRI Development Innovations, LLC|Amgen | Colorectal Cancer | 2010-12 | PHASE2 |
| NCT05901545 | Vanderbilt-Ingram Cancer Center|American Cancer Society, Inc. | Head and Neck Squamous Cell Carcinoma|Recurrent Head and Neck Squamous Cell Carcinoma | 2023-08-22 | PHASE1 |
| NCT01384994 | PD Dr. med. Volker Heinemann|Amgen | Colorectal Cancer|KRAS Wildtype|After Resection of Liver Metastases | 2011-08 | PHASE2 |
| NCT01358812 | Gruppo Oncologico del Nord-Ovest | Metastatic Colo-rectal Cancer | 2010-03 | PHASE2 |
| NCT02162563 | Dutch Colorectal Cancer Group | Colorectal Cancer|Liver Metastases | 2014-07 | PHASE3 |
| NCT01202409 | M.D. Anderson Cancer Center|Amgen | Gastrointestinal Cancer | 2010-11-02 | PHASE2 |
| NCT00578071 | Brian Czito|Amgen | Cancer of the Esophagus | 2007-12 | PHASE1|PHASE2 |
| NCT04117945 | Academic and Community Cancer Research United|National Cancer Institute (NCI) | BRAF V600E Negative|KRAS Gene Mutation Negative|Locally Advanced Unresectable Colorectal Adenocarcinoma|Metastatic Colorectal Adenocarcinoma|NRAS Gene Mutation Negative|Stage III Colorectal Cancer AJCC v8|Stage IIIA Colorectal Cancer AJCC v8|Stage IIIB Colorectal Cancer AJCC v8|Stage IIIC Colorectal Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8 | 2020-03-03 | PHASE2 |
| NCT03300609 | University of Southern California|National Cancer Institute (NCI)|Amgen | Colorectal Adenocarcinoma|RAS Wild Type|Stage III Colorectal Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7 | 2018-02-27 | PHASE3 |
| NCT01927341 | Pfizer | Metastatic Colorectal Cancer | 2013-11-19 | PHASE1|PHASE2 |
| NCT03000374 | Grupo Espanol Multidisciplinario del Cancer Digestivo|Pivotal S.L.|Amgen | Rectal Cancer | 2017-05-30 | PHASE2 |
| NCT00054574 | Jonsson Comprehensive Cancer Center | Prostate Cancer | 2002-11 | PHASE2 |
| NCT02476045 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Metastatic Colorectal Cancer | 2015-06 | PHASE2 |
| NCT01704703 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Stage IV Colorectal Cancer | 2012-10 | PHASE2 |
| NCT00039273 | Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI) | Colorectal Cancer | 2002-07 | PHASE2 |
| NCT00083616 | Amgen | Colorectal Cancer|Metastatic Cancer | 2004-03 | PHASE2 |
| NCT03992456 | Academic and Community Cancer Research United|National Cancer Institute (NCI) | Metastatic Colon Adenocarcinoma|Metastatic Colorectal Carcinoma|Metastatic Rectal Adenocarcinoma|Stage III Colon Cancer AJCC v8|Stage III Colorectal Cancer AJCC v8|Stage III Rectal Cancer AJCC v8|Stage IIIA Colon Cancer AJCC v8|Stage IIIA Colorectal Cancer AJCC v8|Stage IIIA Rectal Cancer AJCC v8|Stage IIIB Colon Cancer AJCC v8|Stage IIIB Colorectal Cancer AJCC v8|Stage IIIB Rectal Cancer AJCC v8|Stage IIIC Colon Cancer AJCC v8|Stage IIIC Colorectal Cancer AJCC v8|Stage IIIC Rectal Cancer AJCC v8|Stage IV Colon Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Rectal Cancer AJCC v8|Stage IVA Colon Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVA Rectal Cancer AJCC v8|Stage IVB Colon Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVB Rectal Cancer AJCC v8|Stage IVC Colon Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8|Stage IVC Rectal Cancer AJCC v8|Unresectable Colon Adenocarcinoma|Unresectable Colorectal Carcinoma|Unresectable Rectal Adenocarcinoma | 2020-04-24 | PHASE2 |
| NCT00389870 | University of Leeds | Colorectal Cancer | 2006-12 | PHASE3 |
| NCT01732783 | Amgen | Wild-type RAS Metastatic Colorectal Cancer | 2012-12-10 | |
| NCT05747625 | Eben Rosenthal|Vanderbilt-Ingram Cancer Center|Vanderbilt University Medical Center | Head and Neck Squamous Cell Carcinoma|Metastatic Head and Neck Squamous Cell Carcinoma|Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck | 2023-05-09 | PHASE1 |
| NCT03360734 | Glycotope GmbH | Solid Tumor, Adult | 2017-11-02 | PHASE1 |
| NCT05084859 | Biosplice Therapeutics, Inc. | Castration-resistant Prostate Cancer|Non-small Cell Lung Cancer|Colorectal Cancer | 2021-11-03 | PHASE1 |
| NCT03366155 | National Cancer Institute (NCI) | Colorectal Cancer|Liver Metastases|Colorectal Adenocarcinoma|Colorectal Cancer With Hepatic Metastases|Colorectal Carcinoma | 2019-06-24 | PHASE2 |
| NCT01288339 | Grupo Espanol Multidisciplinario del Cancer Digestivo|Amgen|TFS Trial Form Support | Metastatic Colorectal Cancer | 2010-11-08 | PHASE2 |
| NCT02415881 | Eben Rosenthal | Head and Neck Cancer | 2016-08 | PHASE1 |
| NCT04425239 | National Cancer Institute, Naples | Colorectal Cancer Stage IV | 2018-05-21 | PHASE2 |
| NCT01175733 | Amsterdam UMC, location VUmc|Amgen | Pancreatic Cancer | 2010-07-08 | PHASE1|PHASE2 |
| NCT00861120 | Vejle Hospital | Epithelial Ovarian Cancer | 2009-04 | PHASE2 |
| NCT03227926 | Fondazione del Piemonte per l´Oncologia | Colorectal Cancer | 2017-10-11 | PHASE2 |
| NCT06268015 | Nicholas DeVito, MD|Gateway for Cancer Research|Agenus Inc. | Colorectal Cancer | 2024-11-18 | PHASE2 |
| NCT01142414 | European Organisation for Research and Treatment of Cancer - EORTC | Head and Neck Cancer | | PHASE3 |
| NCT07172919 | Amgen | Advanced Solid Tumors | 2026-01-02 | PHASE2 |
| NCT03263429 | Vanderbilt-Ingram Cancer Center|National Cancer Institute (NCI)|Calithera Biosciences, Inc | Colorectal Cancer|Metastatic Colorectal Cancer|RAS Wild Type Colorectal Cancer|Refractory Colorectal Cancer | 2017-08-23 | PHASE1|PHASE2 |
| NCT01305772 | Neal Ready|Amgen | Squamous Cell Carcinoma of the Head and Neck | 2011-01 | PHASE2 |
| NCT01009983 | Wake Forest University Health Sciences | Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer | 2010-03 | PHASE2 |
| NCT01262183 | Radboud University Medical Center | Irresectable Squamous Cell or Adenocarcinoma of the Oesophagus | 2011-01 | PHASE2 |
| NCT00446446 | Amgen | Cancer|Carcinoma|Head and Neck Cancer|Metastases|Metastatic Cancer|Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck|Oncology|Squamous Cell Carcinoma|Tumors | 2007-10-30 | PHASE2 |
| NCT01843452 | Centre Hospitalier Universitaire Vaudois | Carcinoma of Anal Canal | 2012-12 | PHASE2 |
| NCT06252649 | Amgen | Metastatic Colorectal Cancer | 2024-07-17 | PHASE3 |
| NCT00500760 | Amgen | Head and Neck Cancer|Squamous Cell Carcinoma | 2007-10-01 | PHASE2 |
| NCT00655499 | GERCOR - Multidisciplinary Oncology Cooperative Group | Colorectal Cancer | 2008-06 | PHASE2 |
| NCT02925234 | The Netherlands Cancer Institute|Amgen|AstraZeneca|Bayer|Bristol-Myers Squibb|Novartis|Roche Pharma AG|Merck Sharp & Dohme LLC|Boehringer Ingelheim|Ipsen|Eisai Inc.|Pfizer|Clovis Oncology - Pharma and|Eli Lilly and Company|Janssen, LP|GlaxoSmithKline|Incyte Corporation|Dutch Cancer Society|Stelvio for Life | Cancer|Tumors|Neoplasm|Neoplasia | 2016-08 | PHASE2 |
| NCT00425035 | Amgen | Advanced Renal Cell Carcinoma | 2003-02 | PHASE2 |
| NCT00630786 | Amgen | Colon Cancer|Colorectal Cancer|Rectal Cancer|Metastatic Colorectal Cancer|Oncology | 2008-01 | PHASE1|PHASE2 |
| NCT00613730 | Amgen | Cancer of Pancreas|Cancer of the Pancreas|Pancreas Cancer|Pancreatic Cancer | 2007-01 | PHASE2 |
| NCT01412957 | Amgen | Metastatic Colorectal Cancer | 2011-11 | PHASE3 |
| NCT06490536 | IFOM ETS - The AIRC Institute of Molecular Oncology | Colon Cancer Stage II|Colon Cancer Stage III | 2024-10-22 | PHASE3 |
| NCT07094113 | Amgen | KRAS Altered Advanced or Metastatic Solid Tumors | 2025-07-31 | PHASE1 |
| NCT05423197 | Stanford University | Head-and-neck Squamous Cell Carcinoma | 2026-06 | PHASE2 |
| NCT01750918 | Novartis Pharmaceuticals | Cancer | 2012-12-19 | PHASE1|PHASE2 |
| NCT03087071 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | EGFR NP_005219.2:p.S492R|KRAS Gene Mutation|MAP2K1 Gene Mutation|Metastatic Colorectal Adenocarcinoma|Refractory Colorectal Adenocarcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7 | 2017-12-29 | PHASE2 |
| NCT03733210 | Andrei Iagaru|National Institutes of Health (NIH)|National Cancer Institute (NCI) | Squamous Cell Carcinoma of the Head and Neck|Carcinoma of the Head and Neck | 2019-01-07 | PHASE1 |
| NCT01061788 | Jeffrey Clarke|NantCell, Inc.|Novartis Pharmaceuticals | Advanced Solid Tumors, Non-small Cell Lung Cancer | 2010-04 | PHASE1 |
| NCT02885753 | Federation Francophone de Cancerologie Digestive | Colorectal Neoplasms | 2016-12 | PHASE3 |
| NCT02508077 | City of Hope Medical Center|National Cancer Institute (NCI) | Recurrent Colorectal Carcinoma|Stage IVA Colorectal Cancer|Stage IVB Colorectal Cancer | 2016-02-16 | PHASE2 |
| NCT00454779 | Amgen | Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck | 2007-01-01 | PHASE2 |
| NCT01257360 | WiSP Wissenschaftlicher Service Pharma GmbH|Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | Rectal Cancer | 2010-12 | PHASE2 |
| NCT03231722 | Gruppo Oncologico del Nord-Ovest | Metastatic Colorectal Cancer | 2017-09-13 | PHASE3 |
| NCT00984217 | University of Pittsburgh|Amgen | Adenoma, Pleomorphic|Mixed Salivary Gland Tumor|Salivary Gland Tumor, Mixed|Syringoma, Chondroid | 2011-08 | PHASE2 |
| NCT00327119 | Amgen | Metastatic Colorectal Cancer | 2006-04 | PHASE2 |
| NCT01916109 | Memorial Sloan Kettering Cancer Center|Amgen | Bladder Cancer | 2013-08 | PHASE2 |
| NCT03442569 | UNC Lineberger Comprehensive Cancer Center|Amgen|Bristol-Myers Squibb | Colon Cancer | 2018-03-09 | PHASE2 |
| NCT02337946 | Takeda | Colorectal Carcinoma | 2014-10-16 | PHASE2 |
| NCT00891930 | NantBioScience, Inc. | Metastatic Colorectal Cancer | 2009-05-05 | PHASE2 |
| NCT01108107 | Vejle Hospital|Herlev Hospital | Colon Cancer | 2010-04 | PHASE2 |
| NCT05694936 | Australasian Gastro-Intestinal Trials Group|Olivia Newton-John Cancer Research Institute | Metastatic Colorectal Cancer | 2023-01-23 | PHASE2 |
| NCT01077999 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Squamous Cell Carcinoma|Adenocarcinoma|Esophageal Cancer|Gastro-esophageal Junction Cancer | 2010-01 | PHASE2 |
| NCT03384238 | George Poultsides|National Cancer Institute (NCI) | Pancreatic Adenocarcinoma | 2018-02-07 | PHASE1|PHASE2 |
| NCT00967655 | Loma Linda Oncology Medical Group, Inc. | Colorectal Cancer | 2009-07 | PHASE2 |
| NCT01206049 | Vejle Hospital | Cholangiocarcinoma | 2010-09 | PHASE2 |
| NCT00973193 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Rectal Cancer | 2009-09 | PHASE2 |
| NCT00798655 | Robert Ferris|Amgen | Cancer of Head|Cancer of Head and Neck|Cancer of Neck|Cancer of the Head|Cancer of the Head and Neck|Cancer of the Neck|Head and Neck Cancer|Head Cancer|Head Neoplasms|Head, Neck Neoplasms|Neck Cancer|Neck Neoplasms|Neoplasms, Head|Neoplasms, Head and Neck|Neoplasms, Neck|Neoplasms, Upper Aerodigestive Tract|UADT Neoplasms|Upper Aerodigestive Tract Neoplasms | 2007-11 | PHASE2 |
| NCT06820463 | AbbVie | Metastatic Colorectal Cancer | 2025-04-24 | PHASE2 |
| NCT02876107 | M.D. Anderson Cancer Center|National Cancer Institute (NCI)|Amgen | Breast Carcinoma|Breast Lump|Edema|Erythema|Estrogen Receptor Negative|HER2+Neu Negative|Inflammatory Breast Carcinoma|Invasive Breast Carcinoma|Peau d´Orange|Progesterone Receptor Negative|Triple-Negative Breast Carcinoma | 2016-10-06 | PHASE2 |
| NCT04342676 | Mansoura University | Colon Cancer Stage III | 2017-03-10 | PHASE3 |
| NCT02199223 | University of Utah | KRAS and NRAS Wild-type Colorectal Cancer | 2014-06 | PHASE1 |
| NCT05845450 | Gruppo Oncologico del Nord-Ovest | Colorectal Cancer|Resectable Colorectal Carcinoma | 2023-05-11 | PHASE2 |
| NCT00948935 | Abramson Cancer Center at Penn Medicine | Biliary Cancer|Cholangiocarcinoma | 2009-04 | PHASE2 |
| NCT00819780 | Amgen | Colon Cancer|Colorectal Cancer|Rectal Cancer|Metastatic Colorectal Cancer | 2009-04-24 | PHASE2 |
| NCT01182610 | Accelerated Community Oncology Research Network|Amgen | Gastroesophageal Adenocarcinoma|Adenocarcinoma of the Distal Esophagus|Adenocarcinomas of the Gastroesophageal Junction|Adenocarcinoma of the Proximal Stomach | 2011-04 | PHASE2 |
| NCT01036087 | M.D. Anderson Cancer Center|Celgene Corporation|Amgen | Breast Cancer | 2010-11 | PHASE2 |
| NCT04587128 | University of Wisconsin, Madison|Doris Duke Charitable Foundation | Metastatic Colorectal Cancer | 2020-10-19 | PHASE2 |
| NCT01581840 | Federation Francophone de Cancerologie Digestive | Epidermoid Carcinoma|Anus | 2016-01 | PHASE1|PHASE2 |
| NCT00879385 | University of Utah|Amgen|Eisai Inc. | Colorectal Cancer | 2009-12 | PHASE1 |
| NCT00867334 | Inova Health Care Services|Novartis Pharmaceuticals | Colorectal Neoplasm|Colorectal Cancer | 2009-06 | PHASE1|PHASE2 |
| NCT01388621 | WiSP Wissenschaftlicher Service Pharma GmbH|ClinAssess GmbH | Ovarian Cancer | 2011-10 | PHASE2 |
| NCT03584711 | Federation Francophone de Cancerologie Digestive|Amgen | Metastatic Colorectal Cancer | 2018-04-26 | PHASE2 |
| NCT01791309 | Memorial Sloan Kettering Cancer Center|Genentech, Inc. | Metastatic Colorectal Cancer | 2013-01 | PHASE1 |
| NCT01801904 | National Cancer Institute, Naples|Azienda Ospedaliera G. Rummo | Metastatic Colorectal Cancer | 2012-12 | PHASE2 |
| NCT01814501 | John Hays|Amgen | Mucinous Adenocarcinoma of the Colon|Mucinous Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Signet Ring Adenocarcinoma of the Colon|Signet Ring Adenocarcinoma of the Rectum|Stage IV Colon Cancer|Stage IV Rectal Cancer | 2013-02-01 | PHASE2 |
| NCT03164655 | UNICANCER | Colorectal Cancer Metastatic | 2018-07-25 | PHASE2 |
| NCT01307956 | University of Nebraska|National Cancer Institute (NCI) | Adenocarcinoma of the Gastroesophageal Junction|Esophageal Adenocarcinoma|Stage IIA Esophageal Cancer|Stage IIB Esophageal Cancer | 2011-02-28 | PHASE2 |
| NCT00820248 | NCIC Clinical Trials Group | Head and Neck Cancer | 2008-12-30 | PHASE3 |
| NCT06314997 | Matteo´s Friends | Recurrence Free Survival | 2019-01-14 | PHASE2 |
| NCT01308840 | University of Rochester|Amgen | Biliary Tract Cancer|Gallbladder Cancer | 2010-12 | PHASE2 |
| NCT00950820 | AIO-Studien-gGmbH|iOMEDICO AG | Colorectal Neoplasms | 2009-09 | PHASE2 |
| NCT01088620 | WiSP Wissenschaftlicher Service Pharma GmbH|Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | Carcinoma, Non-Small-Cell Lung | 2010-04 | PHASE2 |
| NCT00647530 | University of Birmingham | Colorectal Cancer | 2008-05-15 | PHASE2|PHASE3 |
| NCT01264328 | Grupo Espa?ol de Tratamiento de Tumores de Cabeza y Cuello|Amgen|Trial Form Support S.L. | Head and Neck Cancer | 2011-03-09 | PHASE2 |
| NCT01001377 | Amgen | Metastatic Colorectal Cancer | 2010-02-02 | PHASE3 |
| NCT00842257 | Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Dana-Farber Cancer Institute|Amgen | Colorectal Cancer | 2009-05 | PHASE2 |
| NCT00113763 | Amgen | Colorectal Cancer|Metastases | 2004-01-01 | PHASE3 |
| NCT05564377 | National Cancer Institute (NCI) | Advanced Malignant Solid Neoplasm|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Locally Advanced Malignant Solid Neoplasm|Malignant Female Reproductive System Neoplasm|Metastatic HER2-Negative Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Recurrent Endometrial Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Malignant Female Reproductive System Neoplasm|Recurrent Malignant Solid Neoplasm|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Unresectable HER2-Negative Breast Carcinoma|Unresectable Malignant Solid Neoplasm | 2023-04-07 | PHASE2 |
| NCT00475293 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)|Amgen | Metastatic Colorectal Cancer | 2007-05 | PHASE2 |
| NCT03069950 | Memorial Sloan Kettering Cancer Center|The Cleveland Clinic|Oregon Health and Science University|Queens Cancer Center of Queens Hospital|Washington University School of Medicine | Colorectal Adenocarcinoma Metastatic to the Liver | 2017-02-28 | PHASE2 |
| NCT07124884 | Federation Francophone de Cancerologie Digestive|Northwest Oncology Cooperative Group(GONO)|Arbeitsgemeinschaft fur Internistische Onkologie|Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Colorectal Carcinoma|KRAS G12C Mutation|Unresectable Colorectal Cancer | 2025-08-31 | PHASE2 |
| NCT01374789 | WiSP Wissenschaftlicher Service Pharma GmbH|Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | Urinary Bladder Cancer | 2010-07 | PHASE2 |
| NCT01110785 | Leiden University Medical Center | Colorectal Cancer | 2010-04 | PHASE2 |
| NCT03510208 | Stanford University|National Institutes of Health (NIH)|National Cancer Institute (NCI) | Malignant Brain Neoplasm|Malignant Glioma | 2018-05-16 | PHASE1|PHASE2 |
| NCT03311750 | Hellenic Cooperative Oncology Group|Amgen | Advanced Colorectal Cancer | 2018-03-26 | PHASE2 |
| NCT00411450 | Amgen | Colon Cancer|Colorectal Cancer|Rectal Cancer|Cancer|Metastatic Cancer|Metastatic Colorectal Cancer|Oncology | 2006-11 | PHASE2 |
| NCT02394795 | Takeda | Colorectal Cancer | 2015-05-29 | PHASE3 |
| NCT01215539 | Hellenic Cooperative Oncology Group | Colorectal Cancer | 2010-09 | PHASE2 |
| NCT06714357 | National Cancer Institute, Naples | Colorectal Cancer Metastatic | 2025-03-12 | PHASE2 |
| NCT01144195 | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials|Amgen | Metastatic Colorectal Cancer | 2009-09 | PHASE2 |
| NCT05576896 | Northwestern University|National Cancer Institute (NCI) | Stage IV Colorectal Cancer Positive for BRAF V600E Mutation|Colorectal Cancer|Colorectal Cancer Stage IV | 2022-10-10 | PHASE2 |
| NCT01042288 | SCRI Development Innovations, LLC|Amgen | Non-Small-Cell Lung Cancer | 2010-06 | PHASE2 |
| NCT00513383 | Massachusetts General Hospital|Brigham and Women´s Hospital|Amgen | Squamous Cell Carcinoma of the Head and Neck | 2006-04 | PHASE1 |
| NCT00101920 | Amgen | Non-small Cell Lung Cancer|Neoplasm Metastasis|Lung Cancer | 2003-06 | PHASE2 |
| NCT00111774 | Amgen | Colorectal Cancer|Carcinoma | 2002-03 | PHASE2 |
| NCT00061126 | Abgenix|Immunex Corporation | Prostate Cancer | 2003-04 | PHASE2 |
| NCT00034346 | Amgen | Non-Small Cell Lung Cancer|Neoplasm Metastasis|Lung Cancer | 2002-01 | PHASE2 |
| NCT00113776 | Amgen | Colorectal Cancer | | PHASE2 |